eHealth, Inc. (EHTH) Key Metrics
EHTH valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $18.8M
- Enterprise value
- $58.3M
- P/E (TTM)
- — 10-yr median 31.3
- Forward P/E
- 0.5
- PEG ratio
- 0.72
- Price / sales
- 0.0 10-yr median 1.1
- Price / book
- 0.1 10-yr median 1.0
- EV / EBITDA
- 0.8 10-yr median 20.7
- Dividend yield
- —
- Beta
- 1.63
EHTH key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsEHTH valuation Price multiples at each fiscal year-end price.
EHTH returns How much profit the business earns on the capital it uses.
EHTH per-share figures Results divided by the shares outstanding at year-end.
EHTH financial health Debt, liquidity and how easily interest is covered.
EHTH efficiency & capital use Working capital cycle and where the cash goes.
EHTH valuation history
EHTH returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
EHTH debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
EHTH cash returned to shareholders
EHTH price vs earnings per share
EHTH key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $140.2M | $275.7M | $244.3M | $132.4M | $682.9M | $1.91B | $2.36B | $784.1M | $330.8M | $194.6M |
| Enterprise value | $197.4M | $290.4M | $225.8M | $94.8M | $601.1M | $1.86B | $2.37B | $776.2M | $293.9M | $134.8M |
| P/E ratio | 3.5 | 27.4 | — | — | — | 42.0 | 35.2 | — | 13.0 | 640.1 |
| Price / sales | 0.3 | 0.5 | 0.5 | 0.3 | 1.3 | 3.3 | 4.7 | 3.1 | 1.7 | 1.0 |
| Price / book | 0.1 | 0.5 | 0.3 | 0.2 | 0.9 | 2.3 | 4.5 | 2.6 | 1.2 | 2.5 |
| Price / free cash flow | — | — | — | — | — | — | — | — | — | 545.1 |
| Price / operating cash flow | — | — | — | — | — | — | — | — | — | 47.7 |
| EV / sales | 0.4 | 0.5 | 0.5 | 0.2 | 1.1 | 3.2 | 4.7 | 3.1 | 1.5 | 0.7 |
| EV / EBITDA | 2.4 | 6.2 | 765.4 | — | — | 28.1 | 20.7 | 32.9 | — | 16.8 |
| EV / free cash flow | — | — | — | — | — | — | — | — | — | 377.7 |
| Earnings yield | 28.6% | 3.6% | −11.5% | −67.0% | −15.3% | 2.4% | 2.8% | 0.0% | 7.7% | 0.2% |
| Free cash flow yield | −29.0% | −11.3% | −7.2% | −32.0% | −26.9% | −6.9% | −3.7% | −1.8% | −6.2% | 0.2% |
| Dividend yield | 4.2% | 2.0% | 1.4% | 0.0% | 31.3% | 0.1% | 0.2% | — | 0.0% | 0.0% |
| Shareholder yield (dividends + buybacks) | 5.9% | 3.3% | 2.8% | 2.3% | 32.7% | 1.1% | 0.8% | 0.6% | 0.5% | 0.6% |
| Share price at fiscal year-end | $4.60 | $9.40 | $8.72 | $4.84 | $25.50 | $70.61 | $96.08 | $38.42 | $17.37 | $10.65 |
| Per share | ||||||||||
| Revenue per share | $18.17 | $18.15 | $16.16 | $14.82 | $20.10 | $21.57 | $20.63 | $12.32 | $10.01 | $10.58 |
| Earnings per share | $1.31 | $0.34 | −$1.01 | −$3.24 | −$3.90 | $1.68 | $2.73 | $0.01 | $1.33 | $0.02 |
| Operating cash flow per share | −$0.83 | −$0.63 | −$0.24 | −$0.98 | −$6.07 | −$3.99 | −$2.91 | −$0.16 | −$0.82 | $0.22 |
| Free cash flow per share | −$1.33 | −$1.06 | −$0.62 | −$1.55 | −$6.85 | −$4.87 | −$3.60 | −$0.69 | −$1.08 | $0.02 |
| Cash per share | $2.53 | $2.80 | $4.34 | $5.28 | $4.60 | $3.46 | $0.96 | $0.64 | $2.12 | $3.38 |
| Book value per share | $31.94 | $20.06 | $32.27 | $23.79 | $27.99 | $31.00 | $21.48 | $14.85 | $15.05 | $4.25 |
| Tangible book value per share | $31.21 | $19.35 | $9.72 | $15.63 | $21.15 | $29.20 | $19.43 | $12.28 | $13.91 | $3.01 |
| Dividends per share | $0.19 | $0.19 | $0.13 | $0.00 | $7.99 | $0.07 | $0.23 | — | $0.00 | $0.00 |
| Capex per share | $0.50 | $0.44 | $0.38 | $0.57 | $0.78 | $0.88 | $0.69 | $0.53 | $0.27 | $0.20 |
| Debt per share | $4.41 | $3.30 | $3.68 | $3.90 | $1.54 | $1.72 | $1.59 | $0.26 | $0.18 | $0.11 |
| Shares outstanding | 30.5M | 29.3M | 28.0M | 27.4M | 26.8M | 27.0M | 24.5M | 20.4M | 19.0M | 18.3M |
| Change in shares outstanding | +3.9% | +4.7% | +2.4% | +2.2% | −0.9% | +10.1% | +20.2% | +7.2% | +4.2% | +1.5% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 5.1% | 1.3% | −3.6% | −12.7% | −13.2% | 6.7% | 16.1% | 0.1% | 14.0% | 0.4% |
| Return on invested capital (ROIC) | 5.7% | 1.6% | −3.1% | −12.7% | −13.6% | 6.7% | 15.6% | 0.5% | −5.6% | 5.0% |
| Return on assets (ROA) | 3.3% | 0.9% | −2.5% | −7.8% | −9.5% | 5.1% | 11.3% | 0.1% | 10.9% | 0.3% |
| Return on tangible assets | 3.2% | 0.9% | −5.9% | −10.0% | −10.8% | 4.6% | 9.7% | 0.1% | 7.5% | 0.4% |
| Free cash flow margin | −7.3% | −5.9% | −3.9% | −10.5% | −34.1% | −22.6% | −17.5% | −5.6% | −10.8% | 0.2% |
| Income quality (OCF / net income) | −0.63 | −1.83 | — | — | — | −2.37 | −1.07 | −13.40 | −0.61 | 13.43 |
| Financial health | ||||||||||
| Total debt | $134.4M | $96.9M | $103.2M | $106.8M | $41.4M | $46.6M | $39.1M | $5.2M | $3.4M | $2.0M |
| Cash & short-term investments | $77.2M | $82.2M | $121.7M | $144.4M | $123.2M | $93.4M | $23.5M | $13.1M | $40.3M | $61.8M |
| Net debt | $57.1M | $14.7M | −$18.5M | −$37.6M | −$81.9M | −$46.8M | $15.6M | −$7.9M | −$36.9M | −$59.8M |
| Debt / equity | 0.14 | 0.16 | 0.11 | 0.16 | 0.06 | 0.06 | 0.07 | 0.02 | 0.01 | 0.03 |
| Debt / assets | 0.11 | 0.08 | 0.09 | 0.10 | 0.04 | 0.04 | 0.05 | 0.01 | 0.01 | 0.02 |
| Net debt / EBITDA | 0.69 | 0.31 | −62.69 | — | — | −0.71 | 0.14 | −0.33 | — | −7.43 |
| Current ratio | 3.37 | 3.69 | 4.87 | 6.62 | 5.40 | 3.92 | 1.84 | 2.58 | 6.12 | 2.73 |
| Quick ratio | 3.37 | 3.69 | 4.83 | 6.62 | 5.10 | 3.73 | 1.79 | 2.52 | 6.01 | 2.62 |
| Interest coverage | 6.4 | 2.1 | -2.6 | -13.5 | -148.7 | 80.1 | 1.8 | — | — | — |
| Working capital | $235.3M | $258.5M | $303.8M | $340.5M | $332.1M | $246.6M | $95.2M | $95.5M | $130.3M | $48.2M |
| Invested capital | $1.03B | $603.1M | $885.6M | $613.4M | $667.7M | $790.7M | $542.8M | $295.3M | $249.8M | $17.8M |
| Tangible asset value | $951.4M | $567.7M | $272.3M | $427.6M | $566.5M | $788.8M | $476.9M | $250.7M | $265.0M | $54.9M |
| Net current asset value | $45.5M | −$212.5M | $173.1M | −$60.6M | $7.8M | $128.5M | −$6.3M | $20.0M | $83.3M | $44.8M |
| Graham number | $30.72 | $12.44 | — | — | — | $34.26 | $36.30 | $1.99 | $21.26 | $1.26 |
| Graham net-net per share | −$0.94 | −$9.90 | $3.58 | −$4.87 | −$2.60 | $2.39 | −$2.25 | −$0.88 | $2.76 | $2.13 |
| Capital allocation | ||||||||||
| Dividends paid | $5.9M | $5.6M | $3.5M | $0 | $214.0M | $1.9M | $5.5M | — | $0 | $0 |
| Share buybacks (net) | $2.4M | $3.4M | $3.3M | $3.1M | $9.3M | $19.8M | $14.3M | $4.5M | $1.8M | $1.2M |
| Dividend payout ratio | 14.7% | 55.3% | — | — | — | 4.3% | 8.3% | — | 0.0% | 0.0% |
| Dividends + buybacks / free cash flow | — | — | — | — | — | — | — | — | — | 349.6% |
| Capex / revenue | 2.8% | 2.4% | 2.4% | 3.8% | 3.9% | 4.1% | 3.3% | 4.3% | 2.7% | 1.9% |
| Capex / operating cash flow | — | — | — | — | — | — | — | — | — | 91.3% |
| Capex / depreciation | 1.11 | 0.79 | 0.54 | 0.73 | 1.11 | 1.84 | 1.88 | 1.60 | 0.95 | 0.68 |
| Stock-based compensation / revenue | 2.7% | 3.7% | 5.1% | 5.0% | 6.1% | 4.3% | 4.5% | 5.0% | 5.1% | 3.8% |
| R&D / revenue | 9.4% | 10.1% | 13.5% | 19.4% | 15.6% | 11.2% | 9.3% | 12.7% | 17.2% | 16.9% |
| SG&A / revenue | 48.9% | 52.7% | 60.1% | 65.8% | 64.5% | 49.0% | 42.4% | 51.2% | 55.5% | 55.6% |
| Efficiency | ||||||||||
| Days sales outstanding | 165.7 | 174.1 | 199.1 | 227.8 | 163.3 | 124.8 | 113.7 | 180.7 | 115.2 | 17.8 |
| Days of inventory on hand | — | — | 282.3 | 2,533.3 | 3,566.4 | 961.8 | 598.6 | 932.6 | 1,781.7 | 1,128.7 |
| Days payables outstanding | 686.7 | 3,117.5 | 1,435.4 | 2,269.6 | 4,642.3 | 2,747.8 | 2,015.8 | 1,327.7 | 2,620.9 | 1,720.0 |
| Cash conversion cycle (days) | -521.0 | -2,943.3 | -954.0 | 491.5 | -912.6 | -1,661.3 | -1,303.5 | -214.5 | -723.9 | -573.5 |
| Receivables turnover | 2.20 | 2.10 | 1.83 | 1.60 | 2.24 | 2.93 | 3.21 | 2.02 | 3.17 | 20.50 |
| Payables turnover | 0.53 | 0.12 | 0.25 | 0.16 | 0.08 | 0.13 | 0.18 | 0.27 | 0.14 | 0.21 |
| Inventory turnover | — | — | 1.29 | 0.14 | 0.10 | 0.38 | 0.61 | 0.39 | 0.20 | 0.32 |
| Asset turnover | 0.46 | 0.47 | 0.41 | 0.36 | 0.49 | 0.65 | 0.86 | 0.63 | 0.81 | 1.74 |
| Average receivables | $251.5M | $254.0M | $247.0M | $253.0M | $240.8M | $199.2M | $157.6M | $124.5M | $60.2M | $9.4M |
| Average payables | $25.9M | $15.3M | $7.0M | $10.2M | $25.3M | $30.7M | $15.1M | $4.5M | $4.2M | $4.1M |
| Average inventory | — | — | $1.4M | $11.4M | $19.5M | $10.8M | $4.5M | $3.1M | $2.8M | $2.7M |
| Intangibles / total assets | 1.8% | 1.8% | 56.7% | 20.1% | 15.9% | 4.7% | 6.8% | 11.9% | 6.0% | 20.8% |
Computed from EHTH's annual financial statements (latest annual report filed February 26, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
EHTH valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), eHealth traded at 3.5 times earnings, against a 10-year median of 31.3. eHealth earned a return on equity of 5.1% and a return on invested capital of 5.7% in fiscal 2025. It ended the year with $134.4 million of debt and $77.2 million in cash and short-term investments, net debt of $57.1 million. It returned $8.3 million to shareholders: $5.9 million in dividends and $2.4 million in share buybacks. The share count rose 66.8% from 18.3M to 30.5M over 9 years.
See the EHTH income statement, the EHTH chart for price history, or the EHTH stock overview for the latest quote and news.
EHTH key metrics FAQ
What is eHealth's P/E ratio?
eHealth traded at 3.5 times earnings at the end of fiscal 2025.
What is eHealth's EV/EBITDA?
eHealth's enterprise value was 2.4 times EBITDA at the end of fiscal 2025 (enterprise value $197.4 million, EBITDA $83.2 million); the current EV/EBITDA is 0.8.
What is eHealth's return on equity?
eHealth's return on equity (ROE) was 5.1% in fiscal 2025: net income of $40.0 million on average shareholders' equity of $781.0 million.
What is eHealth's ROIC?
eHealth's return on invested capital was 5.7% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does eHealth have?
eHealth had total debt of $134.4 million at the end of fiscal 2025, a debt-to-equity ratio of 0.14 and $57.1 million of net debt (0.69 times EBITDA).
What is eHealth's dividend yield?
eHealth paid $5.9 million in dividends in fiscal 2025 ($0.19 per share), a payout ratio of 14.7%.
Does eHealth buy back its shares?
Yes. eHealth spent $2.4 million on net share repurchases in fiscal 2025 Shares outstanding changed +3.9% over the year, to 30.5M..
What is eHealth's free cash flow yield?
eHealth generated -$40.7 million of free cash flow in fiscal 2025, a free cash flow yield of −29.0% on its market value at year-end ($140.2 million).
What is eHealth's current ratio?
eHealth's current ratio was 3.37 at the end of fiscal 2025: current assets were 3.37 times current liabilities.